Page 8 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Immunic, Inc. beats earnings expectations. Reported EPS is $-0.48, expectations were $-0.51. ....

United States , Noord Holland , Geertr Dhaens , Franziska Burianek , Bob Fox , Daniel Vitt , Jessica Breu , Glenn Whaley , Immunic Inc , Assembly Conference , Association Of European Celiac Society , Amsterdam University Medical Center , Call Transcript February , Fourth Quarter , Year End , Vice President , Investor Relations , Chief Executive Officer , Chief Financial , Avidity Partners , Janus Henderson Investors , Soleus Capital , Adage Capital , Paying Jobs , Visited Countries , Cleveland Clinic ,

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

– Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending Cash Runway Into the Third Quarter of 2025 Based on. ....

United States , Edna Kaplan , Paula Schwartz , Jessica Breu , Daniel Vitt , Immunic Inc , Assembly Conference , Exchange Commission , Development Rd Expenses , Rx Communications Group , Association Of European Coeliac Societies , Program In Relapsing Multiple Sclerosis Ongoing , Trademark Office , Significantly Strengthened Balance Sheet , Three Tranche Private Placement , Extending Cash Runway Into , Third Quarter , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population , All Subtypes , Relapsing Multiple Sclerosis Ongoing , Expanded Vidofludimus Calcium Patent Portfolio , Additional New Patents Granted , Exclusivity Protection Expected Into ,

Immunic reports successful 2023 and prepares for key 2025 milestones

Immunic reports successful 2023 and prepares for key 2025 milestones
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Daniel Vitt , Stephen Gunnion , Immunic Inc ,

EQS-News: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

EQS-News: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Daniel Vitt , Jessica Breu , Paula Schwartz , Edna Kaplan , Immunic Inc , Assembly Conference , Rx Communications Group , Exchange Commission , Development Rd Expenses , Association Of European Coeliac Societies , Program In Relapsing Multiple Sclerosis Ongoing , Trademark Office , Distribution Services , Annual Results , Reports Year End , Provides Corporate Update , Provides Corporate , Strengthened Balance Sheet , Three Tranche Private Placement , Extending Cash Runway Into , Third Quarter , Neuroprotective Activity , Vidofludimus Calcium , Consistent Across , Entire Progressive Multiple Sclerosis Population ,

Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update

Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update ....

United States , Daniel Vitt , Immunic Inc , Biotech Stock News Bites , Chief Executive Officer , Exploring Mining , Crypto Corner , Cannabis News , Financial Results , Corporate Update ,